Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,068
datasets available to search
ShareScore release 0.9.0
Dataset results
1,068 results for “PD-1”
Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT04548271. IPD Sharing: Not stated. Countries: 1. Publications: 9.
PD-1 Inhibitor Combined With 125I Seed Implantation for Hepatocellular Carcinoma's Extrahepatic Metastasis: Efficacy and Safety
ClinicalTrials.gov study NCT06991907. IPD Sharing: NO. Countries: 1. Publications: 1.
PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT03619824. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.
ClinicalTrials.gov study NCT06749899. IPD Sharing: NO. Countries: 1. Publications: 3.
Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)
ClinicalTrials.gov study NCT06385730. IPD Sharing: NO. Countries: 1. Publications: 3.
MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial
ClinicalTrials.gov study NCT03287427. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Tisleilizumab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT04870905. IPD Sharing: UNDECIDED. Countries: 1. Publications: 6.
A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma
ClinicalTrials.gov study NCT04831658. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors
ClinicalTrials.gov study NCT04172454. IPD Sharing: NO. Countries: 1. Publications: 1.
HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC
ClinicalTrials.gov study NCT03869034. IPD Sharing: YES. Countries: 1. Publications: 4.
PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer
ClinicalTrials.gov study NCT06086457. IPD Sharing: YES. Countries: 1. Publications: 3.
Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer
ClinicalTrials.gov study NCT05245474. IPD Sharing: NO. Countries: 1. Publications: 4.
Assessing the Prognosis of TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for HCC by Using Clinical and Imaging Biomarkers
ClinicalTrials.gov study NCT05278195. IPD Sharing: NO. Countries: 1. Publications: 5.
The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM
ClinicalTrials.gov study NCT06427252. IPD Sharing: YES. Countries: 1. Publications: 1.
Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer
ClinicalTrials.gov study NCT04643041. IPD Sharing: NO. Countries: 1. Publications: 5.
A Randomized, Controlled, Multi-center, Phase III Clinical Study to Investigate Recombinant Humanized PD-1 Monoclonal Antibody Injection (JS001) Versus Dacarbazine as the 1st-line Therapy for Unresect
ClinicalTrials.gov study NCT03430297. IPD Sharing: NO. Countries: 1. Publications: 1.
Chemotherapy Combined With Apatinib and PD-1 Antibody
ClinicalTrials.gov study NCT05025033. IPD Sharing: NO. Countries: 1. Publications: 8.
PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer
ClinicalTrials.gov study NCT03638297. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung
ClinicalTrials.gov study NCT05553834. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors
ClinicalTrials.gov study NCT04047290. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.